Vishwas Setia
Vermogen: 13 M $ op 30-06-2026
Vermogen: 13 M $ op 30-06-2026
Vishwas Setia worked as an Investment Banking Summer Associate at Merrill Lynch & Co., Inc. in 2013.
Mr. Setia also worked as Chief Financial Officer at MapLight Therapeutics, Inc. from 2024 to 2026.
Mr. Setia completed an MBA degree at Kellogg School of Management in 2014 and holds an undergraduate degree from Delhi College of Engineering.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-05-2026 | 356.256 ( 0,84% ) | 13 M $ | 30-06-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| MAPLIGHT THERAPEUTICS, INC. | Financieel Directeur/CFO | 18-06-2026 |
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Corporate Officer/Principal | 01-08-2013 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Delhi College of Engineering
Delhi College of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for debilitating central nervous system disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau